
### [MONDO:0020125](http://purl.obolibrary.org/obo/MONDO_0020125)
**Label:** acquired neuromuscular junction disease

**Subclasses:** [MONDO:0018743](http://purl.obolibrary.org/obo/MONDO_0018743) (immune-mediated acquired neuromuscular junction disease), [MONDO:0009688](http://purl.obolibrary.org/obo/MONDO_0009688) (myasthenia gravis), [MONDO:0016468](http://purl.obolibrary.org/obo/MONDO_0016468) (toxin-mediated infectious botulism), [MONDO:0015805](http://purl.obolibrary.org/obo/MONDO_0015805) (intestinal botulism), [MONDO:0005498](http://purl.obolibrary.org/obo/MONDO_0005498) (botulism), 

**Corr. equiv. classes:** [Orphanet:1267](http://www.orpha.net/ORDO/Orphanet_1267), [OMIM:159400](http://purl.obolibrary.org/obo/OMIM_159400), [Orphanet:178481](http://www.orpha.net/ORDO/Orphanet_178481), [OMIM:607085](http://purl.obolibrary.org/obo/OMIM_607085), [Orphanet:464764](http://www.orpha.net/ORDO/Orphanet_464764), [OMIM:254200](http://purl.obolibrary.org/obo/OMIM_254200), [Orphanet:230800](http://www.orpha.net/ORDO/Orphanet_230800), [Orphanet:589](http://www.orpha.net/ORDO/Orphanet_589), 

**Class expressions from DL-Learner:**

- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0030191](http://purl.obolibrary.org/obo/HP_0030191) (Abnormal peripheral nervous system synaptic transmission) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0012535](http://purl.obolibrary.org/obo/HP_0012535) (Abnormal synaptic transmission) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0003398](http://purl.obolibrary.org/obo/HP_0003398) (Abnormal synaptic transmission at the neuromuscular junction) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0030191](http://purl.obolibrary.org/obo/HP_0030191) (Abnormal peripheral nervous system synaptic transmission) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0012535](http://purl.obolibrary.org/obo/HP_0012535) (Abnormal synaptic transmission) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0003398](http://purl.obolibrary.org/obo/HP_0003398) (Abnormal synaptic transmission at the neuromuscular junction) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0000508](http://purl.obolibrary.org/obo/HP_0000508) (Ptosis) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0000508](http://purl.obolibrary.org/obo/HP_0000508) (Ptosis) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 62.50%
- [HP:0030191](http://purl.obolibrary.org/obo/HP_0030191) (Abnormal peripheral nervous system synaptic transmission) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 53.32%


